Showing results (2161-2170 of 10,527) with videos related to

Sort By:
Pageof 1,053
The European Respiratory Journal|December 28, 2020
Childhood maltreatment and lung function: findings from the general populationCarsten Spitzer, Ralf Ewert, Henry Völzke, et al.
The European Respiratory Journal|December 28, 2020
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trialPatricia R M Rocco, Pedro L Silva, Fernanda F Cruz, et al.
The European Respiratory Journal|December 18, 2020
Epidemiology of pleural empyema in English hospitals and the impact of influenzaDavid T Arnold, Fergus W Hamilton, Tim T Morris, et al.
The European Respiratory Journal|December 18, 2020
The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trialChristine R Jenkins, Fu-Qiang Wen, Allison Martin, et al.
The European Respiratory Journal|December 18, 2020
The benefits of a systematic assessment of respiratory health in illness-susceptible athletesJames H Hull, Anna R Jackson, Craig Ranson, et al.
The European Respiratory Journal|December 18, 2020
Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE StudyTài Pham, Antonio Pesenti, Giacomo Bellani, et al.
The European Respiratory Journal|December 18, 2020
Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDSJohnatas Dutra Silva, Yue Su, Carolyn S Calfee, et al.
The European Respiratory Journal|November 13, 2020
Nitrogen dioxide increases the risk of mortality in idiopathic pulmonary fibrosisHee-Young Yoon, Sun-Young Kim, Ok-Jin Kim, et al.
The European Respiratory Journal|July 16, 2021
The rescue of F508del-CFTR by elexacaftor/tezacaftor/ivacaftor (Trikafta) in human airway epithelial cells is underestimated due to the presence of ivacaftorFrédéric Becq, Sandra Mirval, Thomas Carrez, et al.
The European Respiratory Journal|July 16, 2021
Awake prone positioning and oxygen therapy in patients with COVID-19: the APRONOX studyOrlando R Perez-Nieto, Diego Escarraman-Martinez, Manuel A Guerrero-Gutierrez, et al.
Pageof 1,053